Mari Uomoto, Yukihide Ota, Yukio Suzuki, Asuna Yumori, Hiroto Narimatsu, Shiro Koizume, Shinya Sato, Yoshiyasu Nakamura, Shohei Myoba, Norihisa Ohtake, et al. Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study. BMC Cancer. 2024. 24. 1
Regina Wachuka Mbugua, Atsushi Takano, Bayarbat Tsevegjav, Tomoyuki Yokose, Toshinari Yamashita, Yohei Miyagi, Yataro Daigo. Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer. International journal of oncology. 2024. 64. 4
Yasuko OKANO, Kengo USUI, Takeshi HANAMI, Masataka TAGURI, Toshinari YAMASHITA, Yohei MIYAGI. Association Between Polymorphisms of NRF2 and Breast Cancer Risk in Japanese Population. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 2024. 55. 2. 67-73
Yoichiro Okubo, Soji Toda, Mei Kadoya, Shinya Sato, Emi Yoshioka, Chie Hasegawa, Kyoko Ono, Kota Washimi, Tomoyuki Yokose, Yohei Miyagi, et al. Clinicopathological analysis of thyroid carcinomas with the RET and NTRK fusion genes: characterization for genetic analysis. Virchows Archiv : an international journal of pathology. 2024
米国癌学会
, 日本臨床検査医学会
, 日本分子生物学会
, 日本病理学会
, 日本癌学会
, The Molecular Biology Society of Japan
, The Japanese Society of Pathology
, The Japanese Cancer Association
, Japan Society of Laboratory Medicine
, American Association for Cancer Research